Trials / Conditions / Malignant Peripheral Nerve Sheath Tumors

Malignant Peripheral Nerve Sheath Tumors

16 registered clinical trials studyying Malignant Peripheral Nerve Sheath Tumors — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Neurofibromatosis Type 1 Tumor Early Detection Study NCT06515860	David Miller	—
Recruiting	MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154	HRYZ Biotech Co.	Phase 2
Recruiting	A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors NCT05985161	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3 NCT04897321	St. Jude Children's Research Hospital	Phase 1
Recruiting	Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion NCT05245500	Bristol-Myers Squibb	Phase 1
Withdrawn	Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma NCT03880123	Matthew Ingham	Phase 1
Active Not Recruiting	B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT04483778	Seattle Children's Hospital	Phase 1
Completed	SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients Wit NCT03433183	Sarcoma Alliance for Research through Collaboration	Phase 2
Active Not Recruiting	EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults NCT03618381	Seattle Children's Hospital	Phase 1
Unknown	Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas NCT03989596	Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2
Recruiting	Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors NCT03141021	Washington University School of Medicine	—
Unknown	Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Ex NCT03651375	Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2
Terminated	PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors NCT02584647	Gulam Manji	Phase 1 / Phase 2
Completed	SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors NCT01661283	Sarcoma Alliance for Research through Collaboration	Phase 2
Completed	Trial of Dasatinib in Advanced Sarcomas NCT00464620	Sarcoma Alliance for Research through Collaboration	Phase 2
Terminated	Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors NCT00427583	Novartis Pharmaceuticals	Phase 2 / Phase 3